CDLX
Neutral signalScored 2026-08-26 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
Cardlytics, Inc.
- Nom
- Cardlytics, Inc.
- Secteur
- Communication Services
- Industrie
- Advertising Agencies
- Bourse
- NASDAQ
- Capitalisation
- $10.5M
- Employés
- 275
- PDG
- Amit Gupta
- Site web
- https://www.cardlytics.com
- Marché
- FLNTFNGRILLRIZEAMCHXSEAT
Cardlytics, Inc. provides an advertising platform, operating in both the United States and the United Kingdom. Among its key offerings is the Cardlytics platform, a proprietary advertising channel integrated directly into banks' digital environments. This system allows marketers to engage customers through the vast networks of their financial institution partners, leveraging digital avenues such as online portals, mobile applications, email, and various real-time alerts. Furthermore, the company offers the Bridg platform, a comprehensive customer data solution that processes point-of-sale information. This enables marketers to conduct advanced analytics, implement highly targeted loyalty initiatives, and precisely evaluate the performance of their marketing efforts. Cardlytics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 13 461 titres (~53 820,27 $ US)
- Insiders
- Gupta Amit
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$100,570
Avg sell (VWAP, 90d window) $3.22 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-18
- Last synced
-
2026-08-25 17:08:49
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-02 | Gupta Amit | Sell · S | 7,382 | $2.53 | $18,699 | Form 4 |
| 2026-10-01 | Gupta Amit | Sell · S | 10,351 | $2.71 | $28,051 | Form 4 |
| 2026-08-18 | Gupta Amit | Sell · S | 6,676 | $4.03 | $26,911 | Form 4 |
| 2026-08-17 | Gupta Amit | Sell · S | 6,785 | $3.97 | $26,909 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-08-26 Drivers: fundamentals. Moteurs : fondamentaux.
CDLX presents a deeply concerning financial profile with persistent operating losses, negative EBITDA, and a fragile capital structure that renders the 40 liquidity score largely superficial.
The first sentence of the analysis written for CDLX on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Unavailable or mixed. Current ratio 1.75 · operating margin -20% — readings disagree
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 45.0% | 43.4% | 42.2% | 37.7% | 38.7% | |
| Ebit Margin | -39.8% | -64.8% | -41.6% | -155.5% | -46.4% | |
| Ebitda Margin | -28.1% | -54.8% | -32.0% | -140.8% | -33.0% | |
| Operating Profit Margin | -20.2% | -70.2% | -43.9% | -153.3% | -45.9% | |
| Pretax Profit Margin | -44.4% | -68.0% | -43.6% | -156.3% | -51.1% | |
| Continuous Operations Profit Margin | -44.4% | -68.0% | -43.6% | -155.8% | -48.1% | |
| Net Profit Margin | -44.4% | -68.0% | -43.6% | -155.8% | -48.1% | |
| Bottom Line Profit Margin | -44.4% | -68.0% | -43.6% | -155.8% | -48.1% | |
| Current Ratio | 1.751 | 1.195 | 1.308 | 1.004 | 1.096 | |
| Quick Ratio | 1.751 | 1.195 | 1.308 | 1.004 | 1.096 | |
| Solvency Ratio | -0.260 | -0.500 | -0.239 | -0.879 | -0.162 | |
| Cash Ratio | 0.621 | 0.440 | 0.537 | 0.490 | 0.713 | |
| Price To Earnings Ratio | -0.590 | -0.949 | -2.496 | -0.415 | -16.564 | |
| Price To Earnings Growth Ratio | 0.012 | -0.159 | 0.034 | -0.002 | -0.194 | |
| Forward Price To Earnings Growth Ratio | 0.012 | -0.159 | 0.034 | -0.002 | -0.194 | |
| Price To Earnings Diluted Ratio | -0.590 | -0.949 | -2.496 | -0.415 | -16.564 | |
| Price To Earnings Diluted Growth Ratio | 0.012 | -0.159 | 0.034 | -0.002 | -0.194 | |
| Price To Book Ratio | -9.386 | 2.563 | 2.493 | 0.913 | 3.081 | |
| Price To Sales Ratio | 0.262 | 0.645 | 1.087 | 0.647 | 7.967 | |
| Price To Free Cash Flow Ratio | -9.409 | -6.380 | -26.720 | -2.866 | -41.659 | |
| Price To Operating Cash Flow Ratio | 6.575 | -20.333 | -1,816.511 | -3.583 | -55.246 | |
| Debt To Assets Ratio | 0.754 | 0.564 | 0.463 | 0.340 | 0.156 | |
| Debt To Equity Ratio | -33.085 | 3.167 | 1.974 | 1.112 | 0.286 | |
| Debt To Capital Ratio | 1.031 | 0.760 | 0.664 | 0.526 | 0.222 | |
| Long Term Debt To Capital Ratio | 1.032 | 0.706 | 0.656 | 0.516 | 0.211 | |
| Financial Leverage Ratio | -43.891 | 5.611 | 4.259 | 3.267 | 1.830 | |
| Working Capital Turnover Ratio | 5.307 | 6.804 | 11.478 | 18.387 | 1.591 | |
| Operating Cash Flow Ratio | 0.119 | -0.059 | -0.001 | -0.217 | -0.118 | |
| Operating Cash Flow Sales Ratio | 0.040 | -0.032 | -0.001 | -0.181 | -0.144 | |
| Free Cash Flow Operating Cash Flow Ratio | -0.699 | 3.187 | 67.984 | 1.250 | 1.326 | |
| Debt Service Coverage Ratio | -6.157 | -2.785 | -15.986 | -104.899 | -6.248 | |
| Interest Coverage Ratio | -4.435 | -21.959 | -21.942 | -114.616 | -9.533 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | -0.192 | -18.500 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.043 | -0.040 | -0.001 | -0.229 | -0.195 | |
| Capital Expenditure Coverage Ratio | 0.589 | -0.457 | -0.015 | -3.997 | -3.066 | |
| Dividend Paid And Capex Coverage Ratio | 0.589 | -0.457 | -0.015 | -3.997 | -3.066 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -3.479 | -2.199 | -5.155 | -0.729 | -23.715 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 45.1% | ▲1.6% | ▲3.6% |
| Ebit Margin | -39.8% | ▲25.0% | ▲29.8% |
| Ebitda Margin | -28.1% | ▲26.8% | ▲29.7% |
| Operating Profit Margin | -20.2% | ▲50.0% | ▲46.5% |
| Pretax Profit Margin | -44.4% | ▲23.7% | ▲28.3% |
| Continuous Operations Profit Margin | -44.4% | ▲23.7% | ▲27.6% |
| Net Profit Margin | -44.4% | ▲23.7% | ▲27.6% |
| Bottom Line Profit Margin | -44.4% | ▲23.7% | ▲27.6% |
| Current Ratio | 1.751 | ▲0.556 | ▲0.480 |
| Quick Ratio | 1.751 | ▲0.556 | ▲0.480 |
| Solvency Ratio | -0.260 | ▲0.240 | ▲0.148 |
| Cash Ratio | 0.622 | ▲0.181 | ▲0.061 |
| Price To Earnings Ratio | -0.590 | ▲0.359 | ▲3.613 |
| Price To Earnings Growth Ratio | 0.012 | ▲0.171 | ▲0.073 |
| Forward Price To Earnings Growth Ratio | 0.012 | ▲0.171 | ▲0.073 |
| Price To Earnings Diluted Ratio | -0.590 | ▲0.359 | ▲3.613 |
| Price To Earnings Diluted Growth Ratio | 0.012 | ▲0.171 | ▲0.073 |
| Price To Book Ratio | -9.386 | ▼-11.949 | ▼-9.319 |
| Price To Sales Ratio | 0.262 | ▼-0.383 | ▼-1.860 |
| Price To Free Cash Flow Ratio | -9.409 | ▼-3.029 | ▲7.998 |
| Price To Operating Cash Flow Ratio | 6.575 | ▲26.908 | ▲384.394 |
| Debt To Assets Ratio | 0.754 | ▲0.189 | ▲0.298 |
| Debt To Equity Ratio | -33.084 | ▼-36.251 | ▼-27.775 |
| Debt To Capital Ratio | 1.031 | ▲0.271 | ▲0.391 |
| Long Term Debt To Capital Ratio | 1.032 | ▲0.327 | ▲0.408 |
| Financial Leverage Ratio | -43.891 | ▼-49.502 | ▼-38.106 |
| Working Capital Turnover Ratio | 5.307 | ▼-1.497 | ▼-3.407 |
| Operating Cash Flow Ratio | 0.118 | ▲0.178 | ▲0.174 |
| Operating Cash Flow Sales Ratio | 0.040 | ▲0.071 | ▲0.103 |
| Free Cash Flow Operating Cash Flow Ratio | -0.699 | ▼-3.886 | ▼-15.309 |
| Debt Service Coverage Ratio | -6.157 | ▼-3.372 | ▲21.058 |
| Interest Coverage Ratio | -4.435 | ▲17.524 | ▲30.062 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▲0.192 | ▲3.739 |
| Operating Cash Flow Coverage Ratio | 0.043 | ▲0.083 | ▲0.128 |
| Capital Expenditure Coverage Ratio | 0.589 | ▲1.046 | ▲1.978 |
| Dividend Paid And Capex Coverage Ratio | 0.589 | ▲1.046 | ▲1.978 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -3.479 | ▼-1.279 | ▲3.577 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $61.1M | $179.4M | $336.1M | $193.2M | $2.13B | |
| Enterprise value | $227.7M | $335.5M | $510.3M | $306.5M | $2.09B | |
| EV / Sales | 0.98x | 1.21x | 1.65x | 1.03x | 7.83x | |
| EV / Op. cash flow | 24.51x | -38.02x | -2758.54x | -5.69x | -54.30x | |
| EV / Free cash flow | -35.07x | -11.93x | -40.58x | -4.55x | -40.95x | |
| EV / EBITDA | -3.48x | -2.20x | -5.16x | -0.73x | -23.71x | |
| Net debt / EBITDA | -2.54x | -1.02x | -1.76x | -0.27x | 0.41x | |
| Current ratio | 1.75x | 1.20x | 1.31x | 1.00x | 1.10x | |
| Income quality | -0.09x | 0.05x | 0.00x | 0.12x | 0.30x | |
| Graham net-net | -$34 | -$37 | -$69 | -$80 | -$78 | |
| Tax burden | 100.0% | 100.0% | 100.0% | 99.7% | 94.2% | |
| Interest burden | 111.4% | 104.9% | 104.8% | 100.6% | 110.1% | |
| Working capital | $58.9M | $29.0M | $52.8M | $1.1M | $31.4M | |
| Invested capital | $181.7M | $208.8M | $400.3M | $439.7M | $934.0M | |
| Return on assets | -36.2% | -48.2% | -23.5% | -67.3% | -10.2% | |
| Operating ROA | -13.9% | -40.4% | -21.4% | -46.8% | -14.5% | |
| Return on tangible assets | -61.0% | -85.3% | -56.8% | -175.5% | -33.6% | |
| Return on equity | 1590.2% | -270.5% | -99.9% | -219.9% | -18.6% | |
| Return on invested capital | -22.6% | -67.0% | -33.5% | -102.0% | -12.3% | |
| Return on capital employed | -22.7% | -80.2% | -33.7% | -103.5% | -13.1% | |
| Earnings yield | -169.4% | -105.5% | -40.1% | -240.9% | -6.0% | |
| Free cash flow yield | -10.6% | -15.7% | -3.7% | -34.9% | -2.4% | |
| Capex / Op. cash flow | 169.9% | -218.7% | -6698.4% | -25.0% | -32.6% | |
| Capex / Depreciation | 57.6% | 69.2% | 42.0% | 30.8% | 35.2% | |
| Capex / Sales | 6.8% | 6.9% | 4.0% | 4.5% | 4.7% | |
| SG&A / Sales | 37.2% | 39.2% | 37.6% | 52.3% | 49.5% | |
| R&D / Sales | 17.0% | 17.8% | 16.6% | 18.2% | 14.3% | |
| Stock comp / Sales | 12.1% | 14.5% | 13.3% | 15.0% | 18.8% | |
| Intangibles / Total assets | 40.6% | 43.5% | 58.7% | 61.6% | 69.7% | |
| Days sales outstanding | 133d | 140d | 149d | 147d | 160d | |
| Days payables outstanding | 10d | 9d | 9d | 7d | 10d | |
| Operating cycle | 133d | 140d | 149d | 147d | 160d | |
| Cash conversion cycle | 124d | 132d | 140d | 139d | 150d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-06 Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript
- 2026-08-05 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026. "The second quarter shows that our execution is translating directly into results. We were within our guidance across all key metrics, with margins improving every single month of the quarter,” said Amit Gupta, CEO of Cardlytics. “We added new advertiser relationships and deepened our partnerships with existing financial insti.
- 2026-08-03 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). The restricted stock units shall v.
- 2026-07-31 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics'' Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For a.
- 2026-07-29 Cardlytics Appoints Chris Cheng as Chief Legal Officer ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. Cheng brings more than 20 years of legal leadership experience at high-growth technology companies, with deep expertise supporting public companies and partnering with executive teams during periods of transformation. With senior legal experience.
- 2026-07-21 Cardlytics to Report Second Quarter 2026 Results on August 5 [url="]Cardlytics, Inc.[/url] (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August
- 2026-07-21 Cardlytics to Report Second Quarter 2026 Results on August 5 ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close. Conference Call Details: When: August 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the.